Institutional investors purchased a net $989.1 thousand shares of ENTA during the quarter ended September 2014. This may signal that the smart money is gaining interest in this company as the 58.88% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
APEX CAPITAL MANAGEMENT, INC. Bought 536.5 Thousand shares of Enanta Pharmaceuticals In...
EAGLE ASSET MANAGEMENT, INC. Bought 183.8 Thousand shares of Enanta Pharmaceuticals In...